Analyst Ratings for Merrimack Pharmaceuticals (MACK)
MACK Rating Summary
MACK Price Target Summary
- Highest: $13.00 (Guggenheim)
- Lowest: $12.00 (Oppenheimer)
- Average: $12.33
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$12.33 (+137.2%)
Avg. $ Target:
$12.33 (+137.2%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/9/2012 | Guggenheim | New Coverage | Buy (N/A) |
13.00 (N/A) |
6.84 | 5.20 | -23.98% | Details |
| 9/27/2012 | Brean Capital | New Coverage | Buy (N/A) |
12.00 (N/A) |
9.17 | 5.20 | -43.29% | Details |
| 5/8/2012 | Cowen | New Coverage | Outperform (N/A) |
N/A (N/A) |
7.50 | 5.20 | -30.67% | Details |
| 5/8/2012 | Oppenheimer | New Coverage | Outperform (N/A) |
12.00 (N/A) |
7.50 | 5.20 | -30.67% | Details |
